News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
The Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs – JCO Oncology Practice
Dec 27, 2024, 08:06

The Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs – JCO Oncology Practice

JCO Oncology Practice shared an article by Vanessa Mara Samuel on X:

“Evaluating the Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs.”

Evaluating the Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs.

Authors: Vanessa Mara Samuel, et al.

The Economic Impact of Novel Oncology Drug Coverage Through Patient Assistance Programs - JCO Oncology Practice

cancer fight against cancer Global fight against cancer JCO JCO Oncology Practice OncoDaily Oncology patient Vanessa Mara Samuel
Special Coverage
Blog
Jan 29, 2025, 10:27
Robin Zon: Attending South Bend Chamber's Third House Meeting
Insight
Jan 29, 2025, 10:24
Hung Trinh: Advances in CAR T cell therapies and their performance in solid tumors.
Blog
Jan 29, 2025, 10:21
Miguel Bronchud: COVID19 - The Enigma?
Blog
Jan 29, 2025, 10:19
Svetlana Nikic: Precision Oncology Consulting - Oncology Biomarker and Reimbursement Landscaping Analysis Across EU
Blog
Jan 29, 2025, 10:19
Siobhan Freeney: Breast density and the associated risk factors related to mammographic breast cancer screening and breast cancer
Blog
Jan 29, 2025, 10:15
The significant risks associated with total pelvic exenteration for advanced colorectal cancer
Blog
Jan 29, 2025, 10:13
Our goal is to bring hope and progress to those touched by lung cancer - LUNGevity Foundation
Insight
Jan 29, 2025, 10:12
Hung Trinh: How CGT innovations may languish without a concerted focus and investment within AMCs
Blog
Jan 29, 2025, 10:11
Evandro de Azambuja: The prognostic value of residual disease RD biology and gene expression after NAT in HER2-positive EBC
Blog
Jan 29, 2025, 10:09
Michael Chuong: NIH Meeting Cancellations Could Impact Cancer Research
Blog
Jan 29, 2025, 10:07
Parth Sharma: The efficacy of HER-2 targeted therapies in biliary tract cancers
Blog
Jan 29, 2025, 10:06
Maureen Kozicki: Chemotherapy isn’t a one-size-fits-all experience